-
4 days ago | 
pharmacytimes.com | Manish Agrawal |Alana Hippensteele
CommentaryVideoJune 24, 2025Author(s):,Manish Agrawal, MD, explores the evolving role of pharmacists in psychedelic-assisted therapy, highlighting ongoing efforts to develop standardized protocols and the emerging involvement of pharmacy teams in patient education and safety. As interest grows in the therapeutic potential of psychedelics, the role of pharmacists in ensuring safe, effective, and ethically sound care is becoming increasingly important.
-
5 days ago | 
pharmacytimes.com | Alana Hippensteele
For oncology pharmacists, understanding the 505(b)(2) approval pathway and its implications is necessary to effectively navigate the challenges 505(b)(2) drugs are creating for infusion center pharmacies, explained Scott A. Soefje, PharmD, MBA, BCOP, during the Hematology/Oncology Pharmacy Association (HOPA) 2025 Annual Conference in Portland, Oregon.
-
5 days ago | 
pharmacytimes.com | Manish Agrawal |Alana Hippensteele
CommentaryVideoJune 23, 2025Author(s):,Manish Agrawal, MD, discusses the expanding influence of his group-based psychedelic therapy model in oncology and beyond, highlighting its adaptation in military post-traumatic stress disorder (PTSD) research, the sustained benefits of long-term patient integration, and growing institutional interest in psychedelic-assisted therapy.
-
1 week ago | 
pharmacytimes.com | Alana Hippensteele
At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, several studies were presented that have direct implications for the role of oncology pharmacists in the cancer care team.
-
1 week ago | 
pharmacytimes.com | Alana Hippensteele
FeatureArticleJune 20, 2025Author(s):At the 2025 Oncology Pharmacists Connect (OPC) meeting, Kevin Chen, PharmD, MS, BCOP, CPP, reviewed several key studies from the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting significant advancements in the treatment of small cell and non–small cell lung cancer.
-
1 week ago | 
pharmacytimes.com | Alana Hippensteele
Advances in gastrointestinal (GI) oncology are rapidly reshaping therapeutic strategies, particularly as immunotherapy and targeted treatments move into earlier lines of care.
-
1 week ago | 
pharmacytimes.com | Alana Hippensteele
Precision oncology has transformed dramatically over the past 20 years, evolving from an era dominated by empiric cytotoxic chemotherapy to one increasingly defined by tumor genomics, targeted therapies, and personalized treatment paradigms. In a presentation at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, Mya Tran, PharmD, BCOP, described both the promise and the challenges of integrating precision medicine into everyday pharmacy practice.
-
1 week ago | 
pharmacytimes.com | Manish Agrawal |Alana Hippensteele
CommentaryVideoJune 16, 2025Author(s):,Manish Agrawal, MD, discusses emerging research on psychedelic-assisted therapy for patients with cancer, including innovative dyadic treatment models, challenges in capturing meaningful outcomes, and growing interest in integrating psychedelics into oncology and palliative care.
-
1 week ago | 
pharmacytimes.com | Zahra Mahmoudjafari |Alana Hippensteele
CommentaryArticleJune 16, 2025Author(s):,Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, co-chair of the 2025 Oncology Pharmacists Connect (OPC) meeting, discusses what makes the event unique, highlights key sessions, and shares her excitement for the educational and networking opportunities. This year’s Oncology Pharmacists Connect (OPC) meeting, hosted by Pharmacy Times Continuing Education™ (PTCE), is taking place in Austin, Texas, from June 19 to 20, 2025.
-
3 weeks ago | 
pharmacytimes.com | Frank Qian |Alana Hippensteele
CommentaryVideoJune 2, 2025Author(s):,Frank Qian, MD, MPH, discusses the integration of omega-3 fatty acid therapy alongside statins and PCSK9 inhibitors in cardiovascular risk management, highlighting the distinct mechanisms of benefit and lack of significant drug interactions. As the landscape of cardiovascular disease management continues to evolve, understanding the diverse mechanisms and therapeutic roles of omega-3 fatty acids is essential for optimizing patient care.
